Uniqure N V (QURE)

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Uniqure N V Stock (QURE) Company Profile

1-339-970-7000

PAASHEUVELWEG 25A, AMSTERDAM

Nächster Verdiensttermin

Neueste SEC-Einreichungen

QURE's Discussions on Twitter

Uniqure N V Stock (QURE) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-03-17	Hochstufung	UBS	Neutral → Buy
2021-06-15	Eingeleitet	BTIG Research	Buy
2021-05-21	Eingeleitet	UBS	Neutral
2021-04-26	Fortgesetzt	Credit Suisse	Outperform
2021-04-01	Hochstufung	Mizuho	Neutral → Buy
2021-01-07	Hochstufung	Guggenheim	Neutral → Buy
2020-11-24	Eingeleitet	H.C. Wainwright	Buy
2020-11-11	Eingeleitet	Berenberg	Buy
2020-11-09	Eingeleitet	Jefferies	Buy
2020-11-04	Eingeleitet	Cantor Fitzgerald	Overweight
2020-10-23	Eingeleitet	RBC Capital Mkts	Outperform
2020-08-25	Eingeleitet	Raymond James	Strong Buy
2020-07-31	Hochstufung	Robert W. Baird	Neutral → Outperform
2020-06-25	Herabstufung	Mizuho	Buy → Neutral
2020-06-25	Herabstufung	Robert W. Baird	Outperform → Neutral
2020-06-25	Herabstufung	Wells Fargo	Overweight → Equal Weight
2019-12-03	Eingeleitet	Cowen	Outperform
2019-12-03	Eingeleitet	Goldman	Buy
2019-11-05	Eingeleitet	Credit Suisse	Outperform
2019-10-11	Eingeleitet	Stifel	Buy
2019-09-25	Eingeleitet	Bernstein	Outperform
2019-09-12	Eingeleitet	Mizuho	Buy
2019-07-30	Herabstufung	Guggenheim	Buy → Neutral
2019-07-08	Bestätigt	Cantor Fitzgerald	Overweight
2019-04-12	Eingeleitet	Piper Jaffray	Overweight
2019-03-29	Eingeleitet	Robert W. Baird	Outperform

Alle ansehen

Uniqure N V Aktie (QURE) Neueste Nachrichten

Finanzdaten der Uniqure N V-Aktie (QURE)

Uniqure N V-Aktie (QURE) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
CALOZ PIERRE	Chief Operating Officer	Jun 17 '24	Sale	4.81	2,936	14,122	115,707
KLEMT CHRISTIAN	Chief Financial Officer	Jun 17 '24	Sale	4.80	1,611	7,733	164,837
POST LEONARD E	Director	Jun 13 '24	Sale	5.14	2,222	11,421	15,999
Potts Jeannette	Chief Legal Officer	Jun 13 '24	Sale	4.98	4,781	23,809	91,819
Springhorn Jeremy P.	Director	Jun 13 '24	Sale	5.12	2,231	11,423	23,756
Meek David D.	Director	Jun 13 '24	Sale	5.12	2,229	11,412	20,252
Balachandran Madhavan	Director	Jun 13 '24	Sale	5.12	2,231	11,423	23,759
Soteropoulos Paula	Director	Jun 13 '24	Sale	5.14	2,220	11,411	20,203
Gut Robert	Director	Jun 13 '24	Sale	5.12	3,504	17,940	44,165
Kaye Jack	Director	Jun 13 '24	Sale	5.16	2,218	11,445	6,501

Uniqure N V (QURE)

Uniqure N V Stock (QURE) Company Profile

Uniqure N V Stock (QURE) Upgrades & Downgrades

Uniqure N V Aktie (QURE) Neueste Nachrichten

Acadian Asset Management LLC Sells 99,744 Shares of uniQure (NASDAQ:QURE) - MarketBeat

(QURE) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Acadian Asset Management LLC Has $2.30 Million Position in uniQure (NASDAQ:QURE) - Defense World

uniQure (NASDAQ:QURE) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Institutional owners may take dramatic actions as uniQure N.V.'s (NASDAQ:QURE) recent 11% drop adds to one-year losses - Simply Wall St

Gene Therapy Market Size to Reach USD 54.39 Billion By 2032 with CAGR of 23.12%, Boosted by Rising Genetic Disorders and Advances in CRISPR Technology - GlobeNewswire Inc.

Trading (QURE) With Integrated Risk Controls - Stock Traders Daily

uniQure N.V.’s Banking’s 100-Day Moving Average at 5.76: Will the Stock Break Through? - The InvestChronicle

Assenagon Asset Management S.A. Makes New Investment in uniQure (NASDAQ:QURE) - MarketBeat

uniQure Forecasted to Post FY2024 Earnings of ($4.84) Per Share (NASDAQ:QURE) - MarketBeat

FY2024 Earnings Forecast for uniQure Issued By HC Wainwright (NASDAQ:QURE) - Defense World

uniQure retains PT with Buy rating on gene therapy prospects - Investing.com

HC Wainwright Reaffirms "Buy" Rating for uniQure (NASDAQ:QURE) - MarketBeat

HC Wainwright Reaffirms “Buy” Rating for uniQure (NASDAQ:QURE) - Defense World

Is uniQure N.V. (QURE) worth investing in despite its undervalued state? - US Post News

QURE (uniQure NV) Cash From Other Investing Activities : $-366.44 Mil (TTM As of Jun. 2024) - GuruFocus.com

QURE (uniQure NV) Total Inventories : $0.00 Mil (As of Jun. 2024) - GuruFocus.com

uniQure NV (STU:UQ1) 3-Year EPS without NRI Growth Rate : -36.20% (As of Jun. 2024) - GuruFocus.com

QURE (uniQure NV) Change In Receivables : $90.64 Mil (TTM As of Jun. 2024) - GuruFocus.com

Vanguard Group Inc. Raises Position in uniQure (NASDAQ:QURE) - MarketBeat

Vanguard Group Inc. Acquires 109,740 Shares of uniQure (NASDAQ:QURE) - Defense World

uniQure (NASDAQ:QURE) Short Interest Up 20.1% in July - MarketBeat

uniQure NV (STU:UQ1) Inventory-to-Revenue : 0.68 (As of Jun. 2024) - GuruFocus.com

uniQure NV (STU:UQ1) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com

uniQure Begins Phase I/IIa Trial for Fabry Disease Treatment - TipRanks

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease - GlobeNewswire

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease - StockTitan

Analysts Set uniQure (NASDAQ:QURE) Price Target at $18.60 - MarketBeat

uniQure (NASDAQ:QURE) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Implied Volatility Surging for uniQure (QURE) Stock Options - Yahoo Singapore News

Cantor Fitzgerald Weighs in on uniQure's FY2024 Earnings (NASDAQ:QURE) - MarketBeat

uniQure (NASDAQ:QURE) Expected to Earn FY2024 Earnings of ($3.14) Per Share - Defense World

StockNews.com Upgrades uniQure (NASDAQ:QURE) to “Sell” - Defense World

How to Take Advantage of moves in (QURE) - Stock Traders Daily

uniQure: Pullback After Strong Interim Treatment Data Creates Buying Opportunity (QURE) - Seeking Alpha

uniQure (NASDAQ:QURE) Upgraded to "Sell" by StockNews.com - MarketBeat

Leerink Partnrs Comments on uniQure's Q3 2025 Earnings (NASDAQ:QURE) - MarketBeat

Analysts Offer Predictions for uniQure’s Q3 2025 Earnings (NASDAQ:QURE) - Defense World

The Goldman Sachs Group Increases uniQure (NASDAQ:QURE) Price Target to $10.00 - Defense World

uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Simply Wall St

uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

UniQure to cut 65% of workforce, or 300 jobs, in major restructuring (NASDAQ:QURE) - Seeking Alpha

uniQure (NASDAQ:QURE) PT Raised to $10.00 at The Goldman Sachs Group - MarketBeat

UniQure Keeps Cutting Costs With 300 More Jobs To Go - Scrip

UniQure: Q2 Earnings Snapshot - Darien Times

UniQure: Q2 Earnings Snapshot - San Antonio Express-News

UniQure: Q2 Earnings Snapshot - New Haven Register

UniQure: Q2 Earnings Snapshot - The Advocate

UniQure: Q2 Earnings Snapshot - The Washington Post

UniQure: Q2 Earnings Snapshot - San Francisco Chronicle

UniQure (QURE) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Finanzdaten der Uniqure N V-Aktie (QURE)

Umsatz

Nettogewinn

Free Cashflow

ENV

Uniqure N V-Aktie (QURE) Insiderhandel

Ähnlich wie QURE